Author: Tayaza Fadason; Sreemol Gokuladhas; Evgeniia Golovina; Daniel Ho; Sophie Farrow; Denis Nyaga; Hong Pan; Neerja Karnani; Conroy Wong; Antony Cooper; William Schierding; Justin M. O’Sullivan
Title: A transcription regulatory network within the ACE2 locus may promote a pro-viral environment for SARS-CoV-2 by modulating expression of host factors Document date: 2020_4_15
ID: 5r0u2mmo_29
Snippet: Interleukin expression is responsible for irreversible, pathological changes associated with 216 SARS-CoV infection in the lung (e. g. [44] ). Human coronavirus has been shown to fine-tune 217 NF-κB signaling [45] . PIR encodes a non-heme iron binding protein that is a redox switch that 218 modulates the binding of p65 (RelA) to NF-κB responsive promoters [46] . NF-κB regulates 219 multiple immune function aspects, including the production of .....
Document: Interleukin expression is responsible for irreversible, pathological changes associated with 216 SARS-CoV infection in the lung (e. g. [44] ). Human coronavirus has been shown to fine-tune 217 NF-κB signaling [45] . PIR encodes a non-heme iron binding protein that is a redox switch that 218 modulates the binding of p65 (RelA) to NF-κB responsive promoters [46] . NF-κB regulates 219 multiple immune function aspects, including the production of pro-inflammatory 220 cytokines [47] . Therefore, it is notable that repressor regulatory sequences for PIR sit within 221 the ACE2 gene (Fig 2A) . We postulate that the chromatin modifications that silence ACE2 222 expression upon early stage infection activate the PIR repressor ( Fig 2B) . This reduces 223 responsiveness of NF-κB, and thereby delays the expected and needed anti-viral response. The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.14.042002 doi: bioRxiv preprint
Search related documents:
Co phrase search for related documents- anti viral response and human coronavirus: 1
- anti viral response and Interleukin expression: 1
- anti viral response and lung SARS cov infection: 1, 2, 3
- bind protein and early stage infection: 1
- bind protein and human coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- bind protein and immune function: 1, 2
- bind protein and lung SARS cov infection: 1, 2, 3
- chromatin modification and fine tune: 1
- chromatin modification and immune function: 1
- early stage infection and human coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- early stage infection and immune function: 1, 2, 3, 4, 5
- early stage infection and Interleukin expression: 1
- early stage infection and lung SARS cov infection: 1, 2
- fine tune and human coronavirus: 1, 2
- human coronavirus and immune function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- human coronavirus and lung SARS cov infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- human coronavirus and NF κB responsive promoter: 1
- human coronavirus and regulatory sequence: 1, 2, 3
- human coronavirus and responsive promoter: 1
Co phrase search for related documents, hyperlinks ordered by date